Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation THT 2026

LVAD Combined with hiPSC-Cardiomyocyte Transplantation for Advanced Heart Failure: Preliminary Safety and Functional Recovery Results from a Randomized Trial

Presenter: yongfeng Shao

March 03, 2026

Presentation THT 2026

Variation in Primary Graft Dysfunction Prevalence and Management Across Heart Transplant Centers

Presenter: Malachy Belkhelladi

March 03, 2026

Presentation THT 2026

Heart Transplantation for Primary Cardiac Tumors: A Systematic Review of Survival and Recurrence Outcomes

Presenter: Warren Fernandes

March 03, 2026

Presentation THT 2026

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy 

Presenter: David Golombeck

March 02, 2026

Presentation THT 2026

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Presenter: Matthew Ramm

March 02, 2026

Presentation THT 2026

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Presenter: Dena E. Hayes

March 02, 2026

Presentation THT 2026

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Presenter: Caroline Magro

March 02, 2026

Presentation THT 2026

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

Presenter: Neha Parvathala

March 02, 2026

Presentation THT 2026

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

Presenter: Jordan Liebman

March 02, 2026

Presentation THT 2026

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Presenter: Thomas Cascino

March 02, 2026

BIO

Advertisement

LVAD Combined with hiPSC-Cardiomyocyte Transplantation for Advanced Heart Failure: Preliminary Safety and Functional Recovery Results from a Randomized Trial

Variation in Primary Graft Dysfunction Prevalence and Management Across Heart Transplant Centers

Heart Transplantation for Primary Cardiac Tumors: A Systematic Review of Survival and Recurrence Outcomes

Longitudinal ImmuKnow Monitoring One Year After Heart Transplant: Associations with Rejection, Infection, and Cardiac Allograft Vasculopathy

Comparing Predictors of Readmission in LVAD Patients Bridged to Transplant: Psoas Muscle Index versus Pre-Albumin

Heart Transplantation in Adults Over 70 Years: National Trends and Center-Level Variability

Characterizing Hemodynamic Phenotypes In Patients Not Meeting Diagnostic Criteria for Primary Graft Dysfunction

Characterizing the Untapped Pool of HIV+ Donors for Heart Transplantation

Not Quite PGD: Classification of Abnormal Hemodynamic Phenotypes after Heart Transplant

Comparing the Strategy of LVAD versus Heart Transplantation Listing by Age in National US Data: Informing Patient Centered Decision Making

Maryjane Farr, MD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content